Abortifacient Agents
Research News and Information

Saturday, November 21, 2009

[Determination of serum antioxidant capacity after induced abortion]

30 Jul 2009 Free radical oxidation processes are a cause of ageing, cancer, cataract, etc. Antioxidants are agents that are able to suppress these processes. They create a system that determines the antioxidant capacity (AOC) of living tissue. The effect of ... Read more...

Mifepristone followed by high-dose oxytocin drip for second-trimester abortion: a randomized, double-blind, placebo-controlled, pilot study.

30 Jul 2009 OBJECTIVE: To study the effect of mifepristone for priming and induction of second-trimester abortion in conjunction with a high-concentration oxytocin drip. STUDY DESIGN: Prospective, randomized, placebo-controlled, pilot study. Thirty patients ... Read more...

Hysteroscopic surgery of ectopic pregnancy in the cesarean section scar.

29 Jun 2009 STUDY OBJECTIVE: To evaluate the effect of hysteroscopy in the treatment of caesarean section scar pregnancy. DESIGN: Retrospective review. PARTICIPANTS: Thirty-nine patients with cesarean scar pregnancy. INTERVENTIONS: Between January 2006 and June ... Read more...

Latest indexed articles for 'Abortifacient Agents'

These are the very latest articles for this heading:

• [Determination of serum antioxidant capacity after induced abortion] 30 Jul 2009
• Mifepristone followed by high-dose oxytocin drip for second-trimester abortion: a randomized, double-blind, placebo-controlled, pilot study. 30 Jul 2009
• Hysteroscopic surgery of ectopic pregnancy in the cesarean section scar. 29 Jun 2009
• Plan B and the doctrine of double effect. 29 Jun 2009
• Which approach for first trimester miscarriage? 29 Jun 2009
• Inhibitive effect of diphenytriazol on rat cytochrome P450 enzyme in vitro. 29 Jun 2009
• Pharmacologic advances in canine and feline reproduction. 29 Apr 2009
• Choosing medical or surgical terminations of pregnancy in the first trimester: what is the difference? 30 Mar 2009
• The guinea pig as an animal model for developmental and reproductive toxicology studies. 30 Mar 2009
• Recent advances in second-trimester abortion: an evidence-based review. 30 Mar 2009
• [Management of the first trimester miscarriages] 3 Mar 2009
• Cervical preparation with laminaria tents improves induction-to-delivery interval in second- and third-trimester medical termination of pregnancy. 2 Mar 2009
• Safety and efficacy of mid-term pregnancy termination using aglepristone in dogs. 27 Feb 2009
• Acute myocardial infarction following oral methyl-ergometrine intake. 12 Feb 2009
• Group a Streptococcus causing necrotizing fasciitis and toxic shock syndrome after medical termination of pregnancy. 30 Jan 2009
• Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol. 30 Dec 2008
• Early termination of pregnancy. 30 Dec 2008
• Medication abortion as a quality indicator for regional comparisons in Sweden. 2 Dec 2008
• Is ovarian pregnancy a medical illness? Methotrexate treatment failure and rescue by laparoscopic removal. 29 Nov 2008
• Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy. 30 Oct 2008

See a longer list of these articles.

Technical information about 'Abortifacient Agents'

Definition: Chemical substances that interrupt pregnancy after implantation.

Registry Number: 0

Descriptor UI: D000019

Alternative terms: Abortifacient Agents; Agents, Abortifacient; Abortifacients; Contraceptive Agents, Postconception; Agents, Postconception Contraceptive; Postconception Contraceptive Agents;

Related Mesh Headings: Oxytocics;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.875.131; D27.505.954.705.131;

History Note: 75

Technical Notes: do not use /ther use for use of abortifacients as abortifacients